This paper examines the epidemiology of chlamydia among adolescents and young adults in the United States, drawing primarily on CDC surveillance data from 2006. It defines chlamydia as a bacterial sexually transmitted infection caused by Chlamydia trachomatis and describes its transmission, symptoms, and long-term health consequences. The paper reviews demographic and clinical data revealing that teenage girls aged 15–19 carry the highest age-specific infection rates, and it applies the epidemiological triangle framework to explain how agent, host, and environmental factors combine to elevate risk among adolescents. It concludes with a discussion of multilevel prevention strategies, including improved screening, education, and access to healthcare.
Chlamydia is a sexually transmitted disease (STD) caused by the bacterium Chlamydia trachomatis (Van Vranken 2006). It is the most frequently reported bacterial sexually transmitted infection in the United States (Chlamydia – CDC Fact Sheet, 2007). Its prevalence among teenagers is especially noteworthy. Of the more than 650,000 cases reported in 1999, three of every four occurred in persons under the age of 25 (Witmer 2009). The figure has since risen sharply: in 2006, a total of 1,030,911 new infections were reported to the Centers for Disease Control and Prevention (CDC), drawing from all fifty states and the District of Columbia (Chlamydia – CDC Fact Sheet, 2007). It should be noted, however, that this increase was largely attributed to improved detection and reporting by healthcare providers. Whether there has been an actual rise in the spread of the disease itself remains uncertain, although it is certainly possible.
Chlamydia passes very easily between sexual partners and is frequently undetected because infected individuals may not manifest any symptoms. Even individuals who are not sexually active in the conventional sense can contract chlamydia. While the bacteria can be transmitted through sexual intercourse, it can also be spread through oral-genital contact. Chlamydial eye infections occur when a person touches bodily fluids containing the bacteria and then touches his or her eye. Chlamydia can also be passed from a mother to her newborn during delivery (Van Vranken 2006). Even after a person is successfully treated, reinfection is common if their partner has not also been treated.
Chlamydia is a serious infection if left untreated — even in the absence of symptoms — not only because it is contagious but because of its long-term sexual and reproductive health consequences. In girls, chlamydia can infect the urethra and cause inflammation of the cervix, potentially leading to pelvic inflammatory disease (PID), an infection of the uterus, ovaries, or fallopian tubes that can result in infertility and ectopic (tubal) pregnancies later in life. In men, chlamydia can cause inflammation of the urethra and epididymis, the structure that transports sperm (Van Vranken 2006).
Federal chlamydia screening and prevalence monitoring began in 1988, initially undertaken by the CDC in Alaska, Idaho, Oregon, and Washington State. In 1993, screening services for women were expanded to three additional regions, and by 1995 they had been extended to all remaining areas of the country. The types of screening criteria and practices used in CDC studies are not uniform — they vary from state to state and region to region. However, data from all regions are compiled uniformly and compared individually, and all states track the gender and age of persons who have contracted the disease.
According to the CDC's Surveillance 2006 report on chlamydia, the year 2000 marked the first time all fifty states and the District of Columbia had regulations requiring the reporting of chlamydia cases. This means that data collected after 2000 is likely to be the most reliable for assessing the demographic composition of affected groups. In 2006, reported cases of chlamydia exceeded one million for the first time, corresponding to a rate of 347.8 cases per 100,000 population — an increase of 5.6% compared with the rate of 329.4 in 2005. As a point of comparison, the number of reported chlamydial infections was almost three times the number of reported gonorrhea cases.
During 1997–2001, chlamydia rates in the southern United States were slightly higher than in any other region. From 2002 to 2006, however, rates leveled across the Midwest, West, and South, remaining lowest in the Northeast. (Post-2000 data is again likely to be more comprehensive.) In 2006, rates of reported infection increased in the South, West, and Northeast (363.3, 357.9, and 299.0 cases per 100,000 population, respectively) and remained stable in the Midwest (352.4 cases per 100,000).
Women aged 15 to 19 reported the highest age-specific rates of chlamydia in 2006 (2,862.7 cases per 100,000 females), followed closely by women aged 20 to 24 (2,797.0 cases per 100,000 females). However, as the CDC notes, "these increased rates in women may, in part, reflect increased screening in this group" (Chlamydia, 2007, Surveillance 2006). Women in this age group may be more likely to seek gynecological care for birth control or other reproductive health services, leading to incidental diagnoses of chlamydia. Age-specific rates among men, while substantially lower than rates among women, were highest in the 20- to 24-year-old age group (856.9 cases per 100,000 males). The CDC flagged this discrepancy as troubling, noting that "the lower rates among men also suggest that many of the sex partners of women with chlamydia are not being diagnosed or reported as having chlamydia" (Chlamydia, 2007, Surveillance 2006).
"Family planning clinic positivity rates and reporting sources"
"Agent, environment, and host risk factors for teens"
"Analytical and descriptive methods; physical risk factors"
"Education, screening access, and treatment recommendations"
Always verify citation format against your institution’s current style guide requirements.